An open clinical trial of sulphamethoxyp
โ
M. Thornhill; M. Pemberton; J. Buchanan; E. Theaker
๐
Article
๐
2000
๐
John Wiley and Sons
๐
English
โ 396 KB
Twenty-five patients with mucous membrane pemphigoid (MMP), whose oral lesions were unresponsive to topical steroid treatment, were treated with 1 g daily of sulphamethoxypyridazine (SMXP), a long-acting sulphonamide antibiotic, in an open prospective clinical trial. Lesion severity was assessed obj